missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Applied Biosystems™ TaqMan™ Array Rat GPCR Panel
TaqMan™ Array Rat GPCR Panel
Brand: Applied Biosystems™ 4378709
12444.00 SEK valid until 2024-12-31
Use promo code "21651" to get your promotional price.
This item is not returnable.
View return policy
Description
The Applied Biosystems™ TaqMan™ Mouse GPCR Array is an efficient, easy-to-use micro fluidic card for quantitative gene expression analysis of mouse GPCR The TaqMan™ Rat GPCR Array is an efficient, easy-to-use micro fluidic card for quantitative gene expression analysis of rat GPCR genes important in drug discovery. This product is designed with 380 TaqMan™ Gene Expression Assays arrayed in singletons in 384 wells (plus 1 control arrayed in quadruplicate) and is compatible with an upgraded Applied Biosystems 7900HT Fast Real-Time PCR System. The targets include retinal receptors, small molecule receptors, chemokine receptors and others including classic endogenous control targets. GPCR Panels are sold in packs of 4.The GPCR targets selected fall into the 50 subfamilies listed, many of which are drug targets or disease associated —odorant, olfactory, gustatory or pheromone receptors are not included. The array is pre-formatted and inventoried, cost-effective, convenient and easy to use without needing expensive robotics. Results are reproducible and consistent across samples, studies, and labs —the same data quality from card-to-card and lot-to-lot — even with different operators.
Specifications
TaqMan™ Array Rat GPCR Panel | |
4°C | |
TaqMan™ array well contains a single TaqMan™ assay for one 2μL reaction |
384-well Microfluidic Card | |
Cell viability, proliferation and function, pharma and biopharma, real-time PCR (qPCR), target and lead identification and validation | |
4 Cards |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction